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Marine bioprospecting is a promising field of research that has gained interest worldwide 
for the past few decades, and can be characterised as a systematic and purpose oriented 
search for bioactive compounds or genetic material from marine sources. Several 
compounds have been isolated and some have found their way into the commercial 
market. The main aim of this master thesis was to investigate the antibacterial activity of 
bioactive compounds in the extracts of the marine ascidian Halocynthia pyriformis. Two 
other marine organisms Metridium senile and Parastichopus tremulus were also screened 
for antibacterial activity, but they were purified in two other parallel projects.   
Aqueous and organic extracts from H. pyriformis were purified using preparative HPLC 
and screened for antibacterial activity. The antibacterial activity was mostly found in the 
organic fractions against the Gram-positive bacteria E.faecalis, S. aureus and MRSA. 
The active fractions from the primary screening were subjected to a secondary screening 
where they did not display any clear activity. Three of the fractions showed some activity 
and was pooled and refractionated and later subjected to a third screening. The active 
fractions were analysed by ESI-TOF and ESI-Q without obtaining any results. A dose-
response test was carried out to investigate the potency of the raw-extract. Due to weak 
results it was decided to fractionate the organic extract of H. pyriformis once again before 
it was subjected to a new primary screening. This time the fractions were concentrated 
and three of them displayed antibacterial activity and were subjected to MS-analyses in 
positive and negative mode.  
The results from the MS-analyses indicated that one of the fractions contained two active 
compounds with the m/z values 269.2094 and 505.4248. The calculated elemental 
composition proposed the empirical formula C16H28O3 for the molecular weight 268.2021. 
A search in databases containing known bioactive compounds proposed four different 
compounds with the same empirical formula. The elemental composition of the m/z value 
505.4248, proposed two empirical formulas C32H56O4 and C31H54N4. None of these two 
formulas gave any hits in the database over known bioactive compounds. This could 
indicate that this is a novel compound. It was impossible to know the identity of these 
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compounds without analysing them in NMR. NMR analyses require large amounts of 
pure compounds which was difficult to obtain in this thesis.  
 v
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1.1 Marine bioprospecting  
 
From the beginning of time nature has always provided mankind with many essentials, 
ranging from materials to create equipment and tools, to food and medicine. All through 
history the latter has come from terrestrial sources, but lately certain aspects of medical 
sciences have turned their eyes towards the marine environment.   
Roughly 2/3 of the earth is covered by the ocean and this gives a potential great 
enhancement to our medical supply. Many marine organisms living there have been 
forced to adapt to extreme conditions such as low temperatures, high pressure and low 
nutrient levels, and because of this some of them have developed different survival 
strategies that involve bioactive molecules which are different from what can be found in 
terrestrial organisms. These bioactive molecules represent interesting developmental 
opportunities in several human medicinal fields.  
Marine bioprospecting can be characterized as a systematic and purpose-oriented search 
for bioactive compounds or genetic material in marine organisms, for further research, 
innovation and commercialisation. This type of research has become easier to perform 
due to knowledge about the marine environment, and better availability of resources, 
which makes it less difficult to collect marine organisms from areas with extreme 
conditions. Several areas outside the Norwegian coast are yet to be explored and 
scientists are eager to take on that challenge. About 15000 marine natural products [1] 
have been isolated and some of them have even found their way into the commercial 






1.2 MabCent-SFI, Marbank and Marbio 
 
MabCent-SFI is a centre established by the research council of Norway March 2007. It is 
a Centre for Research-based Innovation (CRI) for marine bioactivities and drug discovery 
and is situated in Tromsø. Their main focus is to screen and analyze for compounds that 
have antibacterial, anti-inflammatory, antitumor, anti-diabetic activities as well as 
enzymes and antioxidants in Arctic and sub-Arctic marine organisms from north 
Norwegian waters.   
MabCent and Marbio collaborates tightly with Marbank which is a marine biobank that 
organizes the sampling and storage of marine organisms and produces extracts for 
screening, so they can be used for further research, innovation and commercialisation. 
The actual screening is performed by Marbio which is an automated/high-throughput 




The Phylum Chordata is a line of animals which has a chorda dorsalis (notochord or 
“ryggstreng” in Norwegian) at some point in their life cycle. Chordata differ from other 
phylums in four profound features. Firstly there is a central nervous system on the 
animals back that is developed like a continuous tube-shaped string, the neural tube, 
which becomes the spine; secondly the foetus’s skeletal structure, the notochord, lies 
under the neural tube. Thirdly the digestive tract lays under the notochord, and its upper 
part is shaped like a respiratory organ. Fourthly the big pulsating blood vessel and heart is 
placed on the same side as the abdomen (www.snl.no 08.05.2010)    
 
1.4 Halocynthia pyriformis 
 
Halocynthia pyriformis is of the phylum Chordata (subphylum-Tunicata), in the class 
Ascidiacea. The ascidians are sessile and can be colonial or solitary animals. This class is 
characterized by a thick gelatine or leather like tunic which surrounds the ascidians. They 
have two branchial openings or siphons, one for the feeding current to enter and the other 
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one where the waste is removed. Ascidians have few enemies due to the cellulose like 
tunic that make them tough to digest [2, 3]. The picture of Halocynthia pyriformis is 
shown in figure 1.   
 
Figure 1: Halocynthia pyriformis. The picture is used with permission from Sten-R. Birkely, 
Marbank 
 
H. pyriformis is commonly found along the coast in the northern parts of Norway, 
especially around Bodø, but has also been registered as far south as Stavanger. This 
ascidian is a solitary one, but it also appears in colonies. It can appear in red, orange or 
even white colour, and their body can reach a height of 10 cm. It has leather like cap with 
small unbranched tags in small groups. H. pyriformis is commonly called a Sea peach and 
it can become as big as a grapefruit.  
In addition to H. pyriformis this master thesis also included antibacterial screening of two 
other marine organisms, which were purified in other parallel projects. The first, 
Metridium senile (figure 2), is of the phylum Cnidaria, in the class Anthozoa. It is 
commonly found along the entire Norwegian coast and can have an orange, yellow or 
white colour. The second, Parastichopus tremulus (figure 3), is of the phylum 
Echinodermata, in the class Holothuroidea. It is widespread along the entire Norwegian 
coast. P. tremulus has a beautiful red colour on the back and is white on the abdominal 
side [2].  
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Figure 2: Metridium senile.  
The picture is used with permission from Sten-R. Birkely, Marbank 
 
 
Figure 3: Parastichopus tremulus.  
The picture is used with the permission from Robert A. Johansen, Marbank. 
 
1.5 Known bioactive compounds 
 
Tunicates, the subphylum of Chordata, have according to the literature, yielded 
compounds with cytotoxic characteristics. Ecteinascidin-743 (ET743) [4, 5]  (Trabectedin 
®) was isolated from the tunicate Ecteinascidia turbinate and is an anticancer agent now 
approved in Europe for advanced soft tissue sarcoma.  Dehydrodidemnin B (Aplidin ®) 
[6, 7] is another compound with antitumor effects [8], which is undergoing phase II 
clinical trials [9]. Didemnin B (depsipeptide) and Dolastin 10 (nitrogen-containing 
peptides), and Phthalascidin are other compounds with antitumor activity isolated from 
tunicates [8].  
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From the ascidian body there has been isolated highly sulphated dermatan sulphates. 
They consist of the same backbone structure [4-α-L-IdceA-1→3-β-D-Ga1NAc-1]n but 
can differ when it comes to sulphation substitutions. These compounds have high amount 
of 2-O-sulphated α-L-iduronic acid residues but can have different type of sulphation of 
the N-acetyl-β-D-galactosamine. Halocynthia pyriformis has 4-O-sulphation of the N-
acetyl-β-D-galactosamine residue and it causes their anticoagulant activity [10]. 
Eudistomins are cyclic peptides which have substituted condensed oxathiazepine ring 
systems and they are isolated from Eudistoma Olivaceum a colonial Caribbean tunicate. 
The peptide has shown antiviral activity against Herpes simplex virus type (HSV-1) [11].  
From tunicate species (Didemnum) it has been isolated alkaloids with an unusual 
decahydroquinoline skeleton. They may have the potential of being lead compounds 
against malarial diseases [11].  
 
1.6 Choice of methods 
 
MabCent-SFI has a set of established methods that are used for sample preparation, 
fractionating and screening for bioactivities of materials from marine organisms. The 
methods are developed in such manner that they ensure the possibility of finding a wide 
range of compounds, regardless of how small or big they are. The experiments in this 
thesis are based on the methods established by MabCent-SFI.  
The sample of Halocynthia pyriformis was freeze-dried and extracted first with water and 
subsequently with organic solvents (a mixture of dichloromethane and methanol). This 
gives a rough separation of polar and non polar compounds. The organic and the aqueous 
extract were further purified by high performance liquid chromatography (HPLC).  
The fractions obtained from the HPLC purification were screened for antibacterial 
activity. A series of Gram-positive and Gram-negative bacteria were exposed to the 
fractions. After incubation the inhibition of bacterial growth was determined both 
visually and by UV-spectroscopy. The bacterial strains used in the screening cause 
serious infections in humans.  
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Fractions were subjected to primary and secondary screening and the re-fractionated 
fractions were subjected to third screening. The fractions which showed activity after the 
primary and the third screening were analysed by LC-MS, using two different mass 
separators. Electrospray was used to ionize the samples, and accurate mass of the ions 
was obtained to find the accurate molecular weight and the elemental composition of the 
active compounds. By comparing this information to databases one can find out if the 
compound is already known. This process of identifying and eliminating known bioactive 
compounds is called dereplication. The compounds not found in the databases are 
interesting candidates for further structure elucidation.  
The flow chart gives a simple overview of the process from extraction to LC-MS analysis. 




The extractions were performed to obtain different compounds from the freeze-dried 
material. The solvent or mixture of solvents used in the extractions was chosen based on 
the compounds one wanted to extract. Water was used as a solvent to extract the polar, 
hydrophilic compounds, and a mixture of non polar solvents (dichloromethane and 
methanol) was used to extract non polar lipophilic compounds. 
When screening for unknown bioactive compounds from the marine samples, the 
different properties of the compound when it comes to size, shape, polarity, elemental 
composition and so on, are not known. Therefore the selectivity of the extraction solution 
should be as wide as possible. That is why Marbio has chosen to perform an aqueous 
extraction followed by an organic extraction on the same sample of freeze-dried material.   
The water soluble compounds can be bound to membranes, located in membrane pockets 
or be protected by lipophilic substances. This can cause a problem which can be solved 
by pulverizing the material after freeze-drying it, and this will destroy some of the 
lipophilic pockets where the polar compounds usually get trapped. A different solution 
can be carried out by mixing water with an organic solvent like methanol for instance. 
This will dissolve the lipophilic pockets and extraction of the polar compounds will be 



































Figure 4: Simple overview of the process from extraction to LC-MS analysis.  
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1.8 Antibacterial screening 
 
Bacteria are classified as Gram positive or Gram negative, where the main difference lies 
in their cell wall composition. The cell wall of both bacteria consists of a strong 
peptidoglycan layer, but this layer is thicker in Gram positive and slightly thinner in 
Gram negative bacteria. Further more, the Gram negative bacteria contain a 
lipopolysaccharide layer in their outer membrane, which makes their cell wall 
composition more complex than Gram positive bacteria. Some antimicrobial agents have 
a better effect on Gram positive bacteria than Gram negative bacteria, because of their 
less complex cell wall structure [12].  
Unnecessary use and excessive consumption of antimicrobial agents is closely linked to 
the development of resistance. Bacteria have several different means to obtain and share 
resistance. Among these are mutation and horizontal gene transfer, the latter of these can 
happen by plasmids, transposons and lysogenic bacteriophage [13]. This has led to poor 
or slow treatment of infectious diseases. In spite of this knowledge antibiotic discovery is 
not favoured by most pharmaceutical companies due to many factors, two of those factors 
are that it is time-consuming and technically difficult to produce a novel antibiotic [14]. 
The bacteria used in the bacterial screening were Enterococcus faecalis, Escherichia coli, 
Pseudomonas aeruginosa, Staphylococcus aureus and Methicillin-resistant 
Staphylococcus aureus (MRSA).  
In hospitals, MRSA is the most common resistant bacteria, and it was identified around 
1970 in Europe and a decade later in the United States [15]. Later the reports of 
community-acquired MRSA infections in adults started to grow. The main difference 
between hospital acquired MRSA and the community-acquired MRSA is that the former 
is multidrug resistant. Some bacterial strains such as E. faecalis and P. aeruginosa are 
naturally resistant to many antimicrobial agents. Even though linezolid, which is a rather 
new antibiotic, is effective against this strain, some reports on linezolid-resistant strains 
have been obtained [16]. S.aureus and E.coli is known to cause several of the bacterial 
infections in the community. The latter cause urinary tract infections and clinical 
experience show that treatment with the antibiotic Co-trimoxazole has been effective, 
simple and cheap. However co-trimoxazole-resistant strains have been reported the last 
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few years [13]. This shows that antibiotic treatment of infectious diseases is complex and 




E. faecalis is gram positive cocci, capable of both aerobic and anaerobic respiration. They 
occur naturally in the gut and the infections are endogenously acquired but can also be 
the result of cross-infection from hospitalized patients. They cause urinary tract infections 
and can, in individuals with a suppressed immune system or after surgery, cause severe 
septicaemia [17].    
 
Escherichia coli 
E. coli is a gram negative rod which is capable of anaerobe respiration and can grow at 
temperatures up to 44 ºC. The ones that occur naturally in the gut are involved in 
digestion. The other ones that have virulence factors cause diseases like urinary tract 
infection, septicaemia, neonatal meningitis and diarrheal diseases. They spread by contact 
and via the faecal-oral route and it can also be food-associated [17].  
 
 Pseudomonas aeruginosa 
P. aeruginosa is a gram negative rod capable of aerobic respiration and can not grow 
anaerobically except in the presence of nitrate. The bacteria are opportunistic pathogens 
which mean that they can and will infect most part of the body if the growth conditions 
allow it. Among other diseases it can cause skin infections, burns, pneumonia, urinary 
tract infections and septicaemia. They spread by contact either directly or indirectly from 
moist areas where they like to grow [17].  
 
Staphylococcus aureus  
S. aureus are gram positive cocci which are capable of both aerobic and anaerobic 
respiration. Their natural occurrence in humans is on the skin, in the nose and perineum. 
They are the common cause of several skin infections and this result in an intense 
inflammatory response. The bacteria are spread by contact with another person or it could 
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also be spread by airborne routes. Among other serious infections they are capable of 
causing urinary tract infections, bacteremia and lower respiratory tract infections [17].  
 
Methicillin-resistant Staphylococcus aureus 
MRSA are gram positive cocci which are resistant to methicillin and beta-lactame 
antibiotics. They produce beta-lactamases, enzymes that break down the beta-lactam ring, 
and the antibiotic effect is destroyed. Because of the resistance, the infections caused by 
this strain (they cause the same infections as S. aureus) is harder to treat [17].  
  
1.8.1 Minimum Inhibitory Concentration (MIC) 
 
Minimum Inhibitory Concentration (MIC) is a technique which is used to determine the 
lowest concentration of different antibacterial agents necessary to inhibit visible growth 
of microorganisms after overnight incubation. MIC tests are used to confirm resistance, 
and are used as a tool to determine the activity of new antibacterial agents [17, 18].  
A known concentration of bacteria is inoculated with different concentrations of the 
desired antibiotic agent. Visible clouding indicates that the antibacterial agent has not 
worked and there is a visible growth of bacteria. Such clouding will not take place if the 
antimicrobial agent is successful in inhibiting or killing the bacteria. The MIC value is 
determined by the lowest concentrations of the antibiotic (µg/ml) where no bacterial 
growth is visible.   
 
1.9 High Performance Liquid Chromatography  
 
HPLC is a chromatographic technique which separates non-volatile mixtures into their 
individual components. The principle is that the sample components are carried by a 
mobile phase through a column that contains a stationary phase, where they separate and 
elute one by one at the end of the column. They immediately enter a detector where they 
are measured. The recorded peaks are displayed on a chart called a chromatogram. The 
peak area indicates the quantity of a component, and the retention time, the time it takes 
the substance to get through the column, can give an indication of the components 
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identity, although this indication should not be trusted completely as several different 
compounds might have the same or similar retention times on the same HPLC-system. 
 
1.10  Reversed phase columns 
 
There are several different HPLC columns in use which are used to separate substances 
within a wide polarity and mass range. The most widely used are the so-called reversed 
phase columns where the sorbent in the columns are hydrophobic and the substances will 
undergo hydrophobic interactions with the stationary phase. These interactions diminish 
if you change to a column with shorter hydrophobic groups on the stationary phase.   
The mobile phase used in reversed phase HPLC is an aqueous buffer solution mixed with 
organic solvents such as methanol or acetonitrile. The organic solvent must be miscible 
with water. 
UPLC which is short for Ultra Performance Liquid Chromatography is a technique based 
on the same principle as HPLC, but the speed, sensitivity and the resolution are increased. 
The heightening of all of these is due to one parameter, decreased particle size. This is an 
improvement of the technique and is very useful. 
 
1.11 Mass spectrometry 
 
Mass spectrometry is a technique where the molecular mass of compounds is measured. 
The compounds undergo ionization and then they are separated according to their mass to 
charge ratio (m/z) in a mass separator. The amounts of ions are counted in the detector.  
In this thesis liquid chromatography-mass spectrometry with electrospray ionization (ESI) 






1.12  Liquid Chromatography Mass Spectrometry 
 
LC/MS, also called HPLC/MS, is an analytical technique used worldwide, which 
combines liquid chromatography (separation technique) and mass spectrometry 
(analytical technique). Very basically put the former technique is highly efficient when it 
comes to separating non-volatile mixtures into their component substances, without being 
able to identify them, and the latter, as explained above, can identify the single 
substances, but have some limitations when it comes to dealing with mixtures. However, 
some modern MS-instruments can even separate two ions with exactly the same mass 
from each other based on differences in the shape of the molecules. The combination of 
these two techniques gives almost unlimited possibilities when it comes to separating 
complex mixtures and then identifying the individual substances.  
Electrospray ionization (ESI) is a soft ionization method, meaning it mostly produces 
pseudo-molecular ions without fragmenting them further, and the method takes place 
under atmospheric pressure. ESI can be used to ionize large or small compounds, 
including proteins, peptides and many polar substances. The basic principle behind 
electrospray ionization is that the sample solution passes through a stainless steel 
capillary connected to a high voltage power supply and with the help of heated nitrogen 
gas, an aerosol consisting of many charged droplets is formed. A nebulizer gas (i.e. 
nitrogen) will evaporate neutral solvent molecules from the surface of the charged 
droplets, leading to reduced distance between the charges. This in turn will lead to 
repulsion between the same charges. After a while the surface tension of the liquid can no 
longer compete with the Coulomb repulsion, also known as Coulomb explosion, within 
the droplets, and leads to disintegration of the droplets. These explosions will continue to 
happen until most of the solvent is evaporated and only ions remain in their gaseous 
phase ready to enter a mass separator of choice [19].  
The principle behind the time-of-flight (TOF) mass filter is that molecules with identical 
kinetic energies will travel at different speed according to their masses. Molecules that 
possess higher masses will travel at a lower speed, and use more time to reach the 
detector. Ions are pushed by an electrical pulse through a field-free linear flight tube. The 
flight time, the time an ion uses to reach the detector, is used to calculate the m/z. The 
TOF instruments have some limitations, and the major one is that they have a limited 
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dynamic range, meaning that the detector, after registering an ion, needs time to reset 
itself (deadtime about 5 nanoseconds). If there is a high number concentration of ions 
arriving at the detector, some will remain undetected during the dead time. Another 
limitation is that small differences in kinetic energy of ions with identical m/z values will 
compromise the resolution of the instrument. This problem can be solved by using 
reflectrons which evens out the differences in kinetic energy, because the ions with high 
kinetic energy will penetrate deeper and thus spend more time in the reflectron and vice 
versa. Use of several reflectrons will improve the resolution even further. Another aspect 
influencing the resolution is that the ions are located at different distances to the pusher. 
The latter issue can be resolved by focusing the ions to a narrow beam by electrical lenses 
so that the ions undergo orthogonal acceleration.  
The main advantages of TOF (figure 5) are unlimited mass range, high resolution, fast 
and efficient analyses and the small amount of sample required for detection. The 
elemental composition of the analyte is calculated based on the accurate mass and the 
isotopic distribution. The accuracy of the mass measurements can be improved by using 
internal mass calibration which means performing reference scans throughout the 
analysis. The ion source has two probes, a reference and an analyte probe. A reference 
scan is performed every 10.-15. seconds to correct the analyte scans [20].  
 
 




As the name indicates the quadrupole is a mass analyser made up by four cylindrical rods, 
which are paired off diagonally in their charge. An alternating current is applied between 
the electrically connected pairs, and in addition a direct current voltage is applied at the 
top of the alternating current. This causes the charge to alternate between positive and 
negative with very high frequency and in this way ions are guided through the axis of the 
quadrupole. Adjusting the currents to specific values allow the selection of specific ions 
with a certain m/z ratio to pass through the quadrupoles. This can be used to select one 
specific ion or scan a wide range of ions. Thus this is useful in situation where you are 
looking for known compounds and test samples with unknown content. A drawback is 
that the quadrupole looses some sensitivity when scanning for a wide range of ions, but 
then again it is advantageous when looking for one specific compound or in quantitative 
analyses. The quadrupoles are also the most common mass separators used for LC-MS 
ESI-QqQ instruments (figure 6). The main drawback for the quadrupole mass analysers is 
that they have low mass resolution. 
 
 





1.13  The aim of the thesis 
 
The aim of this master thesis was to investigate antibacterial activity of bioactive 
compounds in extracts from H. pyriformis. In addition two other organisms named 
Metridium senile and Parastichopus tremulus were screened for antibacterial activity.  
Two different kinds of extractions were performed, one with water and the other one with 
a mixture of DCM and MeOH at a 1:1 ratio. This was done to get a wider range of 
compounds extracted that was subjected to screening. The antibacterial activity tested 
against five different bacterial strains included both Gram-positive and Gram-negative 
bacteria. Finally it was attempted to purify and identify known bioactive compounds 
searching in databases that could contain information about these compounds.  
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2 Material and methods 
2.1 Sampling and storage 
 
Halocynthia pyriformis, identification number M09038, was collected in 
Porsangerfjorden May 29th 2009 at 20 meters depth by divers. The marine organism was 





IKA A11 Basic     IKA Works; Staufen, Germany 




The frozen sample was cut in pieces of approximately 1 cm3 on a wooden trey and placed 
in glass containers. After the sample was weighed, it was immediately stored at -20 °C. 
The sample was freeze-dried for three days and then crushed and pulverized, and 
transferred to Duran bottles and weighed.  
The extractions were performed with two different methods, one for the aqueous extract 
and the other for the organic extract as described in the next chapter. 
 
2.3 Extraction and HPLC fractionation of aqueous extracts 
2.3.1 Materials  
 
Rotary evaporator, Laborata 4002   Heidolph Nürnberg, Germany 
Freeze drier, Heto PowerDry PL 9000  Thermo Waltham, USA 
22 µm Millex GS filter    Millipore Billerica MA, USA 
Shaker Heidolph Titramax    Heidolph Nürnberg, Germany 
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Waters 600 Controller    Waters MA, USA 
Waters 2996 Photodiode Array Detector  Waters MA, USA 
Atlantis Prep C-18 (10x250 mm; 10 µm)  Waters MA, USA 
MassLynx v.4.1 software    Micromass Manchester, UK 
Waters 600E Multisolvent Delivery System              Waters MA, USA 
Waters Prep Degasser                                                 Waters MA, USA 
Waters 2767 Sample Manager   Waters MA, USA 
Milli-Q Water      Millipore Billerica MA, USA 
Dichloromethane     Merck Darmstadt, Germany 
Methanol      Merck Darmstadt, Germany                                         
Ethanol      Merck Darmstadt, Germany  
Acetonitrile      Merck Darmstadt, Germany 
Hexane      Merck Darmstadt, Germany 




The Duran bottle containing the freeze-dried material was added Milli-Q water 
approximately ten times its dry weight. The total amount of Milli-Q water added was 860 
mL, but it was added in smaller amounts such as 250, 210, 150, 250 mL to the freeze-
dried material and the suspension was shaken vigorously between each step. The 
suspension was shaken once more before it was placed in the refrigerator at 5 °C over 
night.  
The suspension was shaken once more the next day before it was divided in two, and 
transferred to two centrifugation bottles and centrifuged for 30 minutes at 4000 rpm at 5 
°C. The supernatant was decanted and stored, while the pellet was re-extracted with 430 
ml Milli-Q water (approximately half of what was added the first time) and shaken 
vigorously before it was placed in the refrigerator at 5 °C for 30 minutes. The suspension 
was centrifuged once again at 5 °C for 30 minutes. The two supernatants were pooled and 
freezed at -20 °C. This was done to reduce the time of freeze-drying. Afterwards they 
were freeze-dried for three days. The pellet was stored in the freezer at -80 °C.  
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The freeze-dried extracts were pulverized and stored in centrifugation tubes at -20°C after 
being weighed. Afterwards, 211.8 mg of the freeze-dried extract was transferred to a 13 
mL polystyrene centrifugation tube and 2 mL Milli-Q water was added. This was mixed 
for 90 minutes at 100 rpm. Then 1 mL of the aqueous phase was transferred to a new 
centrifugation tube and 4 mL 96% ethanol was added, the mixture was shaken on a mini 
shaker and kept over night at -20 °C.  
The sample was taken out of the freezer and kept at room temperature for 5-10 minutes, 
and centrifuged at 5 °C for 30 minutes at 4000 rpm. The supernatant was transferred to a 
25 mL rotary evaporation flask and vacuum evaporated at 40 °C down to approximately 
2 mL at 70 mbar pressure. The sample was divided on two 1 mL centrifugation tubes and 
the volume adjusted to 1 mL with Milli-Q water. Both tubes were centrifuged for 30 
minutes at 13000 rpm. The supernatants were filtered through 0.22 µm filters into test 
tubes, mixed and then adjusted to 2x1 mL with Milli-Q water. 
The aqueous extracts were ready to be fractionated and two injections of the extract were 
injected. The flow rate was 6 ml/min and the eluent was collected over a time span of 40 
minutes resulting in 2x40 identical fractions. The mobile phase gradient is shown in table 
1.  
 
Table 1: Mobile phase gradient of the aqueous extract M09038 
Flow (ml/min) Tid (min) MP  MP Curve
A % B%
6 0 95 5
6 3 95 5
6 30 50 50
6 35 5 95
6 40 5 95
6 41 95 5

















Rotary evaporator Laborata 4002   Heidolph Nürnberg, Germany 
FreezHeto Powerdry PL9000    Thermo Waltman, USA 
Centrifuge Multifuge 3 S-R Heraeus   Heraeus Instruments Newport  
       Pagnell, England 
Whatman no 3 filter     Whatman Maidstone, England 
Millex GS filter     Millipore Billerica MA, USA 
Waters 600 Controller    Waters MA, USA 
Waters 2996 Photodiode Array Detector  Waters MA, USA 
XTerra® Prep RP18 (10x300 mm; 10 mm)  Waters MA, USA 
MassLynx v.4.1 software    Micromass Manchester, UK 
Waters 600E Multisolvent Delivery System  Waters MA, USA 
Waters Prep Degasser     Waters MA, USA 
Waters 2767 Sample Manager    Waters MA, USA 
Milli-Q Water      Millipore Billerica MA, USA 
Dichloromethane     Merck Darmstadt, Germany 
Methanol      Merck Darmstadt, Germany                                              
Acetonitrile      Merck Darmstadt, Germany 
Hexane      Merck Darmstadt, Germany 
Ethanol 96 %      Merck Darmstadt, Germany 




The remaining pellet after the aqueous extraction had been stored in the freezer, and was 
now freeze-dried and pulverized before it was transferred to a Duran bottle. The 
pulverized material was added a mixture of DCM and MeOH (1:1) at a 10:1 ratio. About 
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200 mL of this mixture was added to the sample in two rounds. The sample was shaken 
vigorously and the suspension was left over night at 5 °C.  
The suspension was vacuum filtered, and the extraction was repeated and the suspension 
was stored at 5 °C for 30 minutes. The filtrate was vacuum evaporated using a rotary 
evaporator. This was done at 40 °C and atmospheric pressure (1000 mbar) and the 
pressure was gradually reduced to 180 mbar.  A viscous liquid of approximately 10-20 
mL remained in the evaporation flask. This was transferred to 3 test tubes and stored in 
the freezer (-20 °C).  
The test tube containing the organic extract was stored at room temperature for a couple 
of minutes. Approximately 100-300 mg was weighed and transferred to a test tube of 13 
mm diameter and 3 mL hexane and 3 mL of 90 % ACN were subsequently added. The 
mixture was shaken vigorously between each addition. The test tube was centrifuged at 
300 rpm for 3 minutes, and the ACN phase was transferred to an evaporation flask. 
Another 3 mL of 90 % ACN was added to the hexane phase and stirred vigorously. The 
centrifugation was repeated and the two ACN phases were pooled in the same 
evaporation flask. All of this was done in two parallels. The pooled ACN phases were 
vacuum evaporated at 40 °C. The pressure was gradually reduced to 180-150 mbar. The 
remaining 2 mL were divided on two centrifugation tubes and the volume was adjusted to 
1 mL in each tube, and then stored at -20 °C.  
The organic extracts were left at room temperature and centrifuged at 13000 rpm for 30 
minutes. The liquid phase in both were pooled and transferred to one tube. The volume 
was divided between two test tubes and adjusted to 1 mL with 90 % ACN, and they were 
ready to be fractionated. Two injections of the extract were injected. The flow rate was 6 
mL/min and the eluent was collected in one-minute fractions over a time span of 40 
minutes, resulting in 2x40 identical fractions. The mobile phase gradient used is shown in 










Table 2: Mobile phase gradient for the organic extract M09038 
Flow (ml/min) Tid (min) MP  MP Curve
A % B%
6 0 80 20 -
6 2 80 20 6
6 30 0 100 6
6 40 0 100 6
6 41 80 20




2.5 Re-fractionation of active fractions 
2.5.1 Materials 
 
Waters 600E Multisolvent Delivery System   Waters MA, USA 
Waters Prep Degasser      Waters MA, USA 
2767 Sample Manager     Waters MA, USA                      
Waters 2996 Photodiode Array Detector   Waters MA, USA 
Symmetry prep C18 7 µm; 7.8x300 mm   Waters MA, USA 
MassLynx v.4.1 software     Micromass Manchester, UK 
MeOH        Merck Darmstadt, Germany 
Formic acid       Merck Darmstadt, Germany  
Milli-Q water       Millipore Billerica MA, USA 




The aqueous fractions from M09038-0-W01 did not display any clear activity and was 
not re-fractionated. Active fractions from the second screening were subject to re-
fractionation. Fraction no 24, 25 and 26 from M09038-0-L01 (three deep well plates) 
were pooled and dissolved in 200 µL MeOH 80 % and shaken for approximately one 
hour, and then transferred to test tubes. Another 100 µL MeOH 80 % was added to the 
same wells and shaken for approximately 30 minutes and transferred to the same test tube. 
The test tube was vacuum centrifuged for one hour. The volume was 475 µL.  
 
 29
Approximately 100 µL pure ACN was added to the test tube. The volume injected into 
the HPLC column was 575 µL. This was to ensure that the lipid soluble substances would 
dissolve and not make aggregates with water. The flow rate was 4 mL/min. The mobile 
phase gradient used is shown in table 3. Afterwards the 40 fractions were divided on 
three deep well plates. The three plates were vacuum centrifuged for 1.5 hours, frozen at -
20 °C and freeze-dried for two days.  
 
Table 3: Mobile phase gradient for the re-fractionated fractions  
Flow (ml/min) Tid (min) MP  MP Curve
A % B%
4 0 30 70 -
4 30 0 100 6
4 40 0 100 6  
 
2.6 New Primary fractionation 
 
Based on the poor dose-response results it was decided to fractionate the organic extract 
M09038 once again into 40 fractions by a different HPLC machine than the one used 
earlier. The procedure was the same and the gradient used is shown in table 2. The 
column used was XbridgeTM Prep C18 5 µm 10x250 mm. This time the fractions were 
more concentrated before they were subjected to new primary screening and ESI-MS.  
The two other marine organisms labelled M09036-0-L01 and M09037-0-L01 underwent 
the same sample preparation as M09038-0-L01. The marine organism M09037-0-L01 
was not subjected to new primary screening.  
 
2.7 Solubilisation of HPLC fractions 
 
Organic fractions were dissolved in 7.5 µL DMSO and shaken at 400 rounds per minute 
(rpm) for two hours. Each fraction was added 750 µL autoclaved Milli-Q water before 
shaking them for another 30 minutes. Another round of 750 µL autoclaved Milli-Q water 
was added to the fractions and they were once again shaken for 30 minutes.  
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Aqueous fractions were dissolved in 750 µL autoclaved Milli-Q water and shaken as 
above for 30 minutes before adding another round of 750 µl autoclaved Milli-Q water 
followed by two hours of shaking. 
 
2.8 Antibacterial screening 
2.8.1 Materials 
 
Microtiter plate      Nunc Roskilde, Denmark   
Shakeincubator – Heidolph Incubator 1000   Heidolph Nürnberg, Germany 
Blood plates      Media kitchen, UNN 
Iso-Sensitest-Agar plates (ISA)    Media kitchen, UNN    
Victor 3 TM 1420 Multilabel Counter  Perkin Elmer Instruments;  
Shelton, USA 
Brain Heart Infusion (BHI)    Oxoid, England                                                                 
Mueller Hinton II (MH)    Dickinson and Company, France  
DMSO       Sigma Aldrich München, Germany 
Autoclaved Milli-Q water    Millipore Billerica MA, USA 




The bacterial strains used in the antibacterial screening were E. faecalis, E. coli, P. 
aeruginosa and MRSA. Each bacterial strain was plated out on separate blood plates. 
These were incubated in the refrigerator at 5 ºC for 3 days before they were used.  
 
Day 1: Cultivation of bacteria 
The bacterial strains were inoculated in 8 mL cultivation media table and incubated at 37 




Day 2: Experimental procedure 
From the bacterial strains from the previous day 2 mL was transferred to 25 mL of fresh 
media for enrichment in order to achieve exponential growth. The bacterial suspensions 
were incubated at 37 ºC and shaken for 1.5 to 2.5 hours depending on the time needed to 
enter the logarithmic phase of the growth curve as seen in table 4. The bacterial strains 
were cultivated until their growth reached a turbidity of 0.5 McFarland standard (1.0x108 
bacteria/mL). 
 
Table 4: Bacteria, cultivation media, incubation period and bacterial density 
Bacteria Cultivation media Inc. period Density of bacteria
E. faecalis BHI 1,5 h 0,5-3x10 CFU/ml
E. coli MH 1,5 h 0,5-3x10 CFU/ml
P. aeruginosa MH 2,5 h 3-7x10 CFU/ml
S. aureus MH 2,5 h 0,5-3x10 CFU/ml
MRSA MH 2,5 h 0,5-3x10 CFU/ml  
 
For each bacterial strain, 50 µL HPLC fraction and 50 µL bacterial suspensions were 
added to a 96-well microtiter plate as shown in figure 4. The bacterial suspensions were 
diluted 1:100 and finally 1:10 in cultivation media before adding 50 µL to each fraction. 
This has to happen within 30 minutes to maintain viable cell density. The plates were 
incubated at 37º C over night.  
 
N 1 1 9 9 17 17 25 25 33 33 P
N 2 2 10 10 18 18 26 26 34 34 P
N 3 3 11 11 19 19 27 27 35 35 P
N 4 4 12 12 20 20 28 28 36 36 P
N 5 5 13 13 21 21 29 29 37 37 P
N 6 6 14 14 22 22 30 30 38 38 P
N 7 7 15 15 23 23 31 31 39 39 P
N 8 8 16 16 24 24 32 32 40 40 P  
Figure 4: HPLC fractions added to the assay plate in parallels. N (negative control) and P (positive 
control).  
 
The negative control consisted of 50 µL cultivation media + 50 µL autoclaved Milli-Q 
water and was added to column number 1. The positive control consisted of 50 µL 
autoclaved Milli-Q water + 50 µL bacterial suspension and was added to column number 
12. The antibacterial agent gentamicin was used as control for the setup and precision 
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between the tests (MIC). A series of dilution were made with the following 
concentrations of gentamicin: 30µg/mL- 20 µg/mL - 16µg/mL - 8 µg/mL - 4µg/mL - 
2µg/mL - 1µg/mL - 0.5µg/mL – 0.25µg/mL – 0.12 µg/mL – 0.06µg/mL – 0.03µg/mL. It 
was not made a series of dilution of the HPLC fractions because the concentration of 
potential antimicrobial compounds is unknown.   
To estimate the number of bacteria the suspensions had to be diluted to approximately 
1x102-1x103 bacteria/mL. The suspensions were diluted with 0.9 % NaCl in the following 
manner: 1) 1:100, 2) 1:100, 3) 1:10, 4) 1:10. 100 µL from dilution number 4 was plated 
out on ISA plates in two parallels and incubated at 37 ºC over night.  
 
Day 3: Results 
Visible clouding indicates bacterial growth and inactive (I) fractions. Wells that do not 
show visible clouding indicate inhibition of bacterial growth and active (A) fractions. The 
assay plates were subject to a photometric reading at optical density (OD) at 600 nm. The 
photometric values for the active (A), questionable (Q), or inactive (I) fractions were 
defined as following with an absorbance at: A <0.05 Q 0.05-0.09 and I >0.09 
 
Active fractions from the first screening were subject to a secondary screening also called 
a re-test. This was done to confirm the fractions as active and to find dose-response 
relationship in 1:1, 1:2 and 1:4 dilutions as shown in figure. If the fractions were 
confirmed as active in this second screening, a third screening was performed on re-
fractionated fractions. The method used during the second and the third screening was the 
same as the first screening.   
 
N A (U) A (1:2) A (1:4) E (U) E (1:2) E (1:4) I (U) I (1:2) I (1:4) P
N A (U) A (1:2) A (1:4) E (U) E (1:2) E (1:4) I (U) I (1:2) I (1:4) P
N  B (U) B (1:2) B (1:4) F (U) F (1:2) F (1:4) J (U) J (1:2) J (1:4) P
N  B (U) B (1:2) B (1:4) F (U) F (1:2) F (1:4) J (U) J (1:2) J (1:4) P
N C (U) C (1:2) C (1:4) G (U) G (1:2) G (1:4) K (U) K (1:2) K (1:4) P
N C (U) C (1:2) C (1:4) G (U) G (1:2) G (1:4) K (U) K (1:2) K (1:4) P
N D (U) D (1:2) D (1:4) H (U) H (1:2) H (1:4) L (U) L (1:2) L (1:4) P
N D (U) D (1:2) D (1:4) H (U) H (1:2) H (1:4) L (U) L (1:2) L (1:4) P  
Figure 5: HPLC fractions added to assay plate in U (undiluted), 1:1, 1:2 and 1:4 dilutions in the 
secondary screening. The letters represents the different fractions.   
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2.9 Dose-response of organic extract 
 
A dose-response test was carried out to calculate how potent the organic raw-extract of 
M09038 was.  
The organic extract M09038-0-L01 was taken out of the freezer and left at room 
temperature. About 500 mg was transferred to a 13 mm diameter test tube and then 3 mL 
hexane and 3 mL 90 % ACN was added. The test tube was shaken between each addition. 
The mixture was centrifuged at 300 rpm for three minutes. This was performed in two 
parallels. The lower phase (ACN) was transferred to a new test tube. The upper phase 
(hexane) was added 3 ml 90 % ACN and shaken before centrifuged for further three 
minutes. The test tube containing the ACN phase was vacuum centrifuged for a couple of 
hours until it was dry.  
The dried sample was dissolved in 200 µL DMSO and shaken on a mini shaker until it 
was fully dissolved. Later a series of dilutions were made. The concentrations of the 
dilutions were: 500-250-100-50-25-12.5-10-5-2.5-1-0.5-0 µg/mL. The dilutions were 
further subjected to antibacterial screening.  
 
2.10  LC-MS analyses 
2.10.1 Materials 
 
Waters Quattro Premier XE MS    Waters MA, USA 
Waters Nano Acquity UPLC     Waters MA, USA 
Waters Acquity UPLC BEH C18, 1.0x150mm, 1.7µm Waters MA, USA 
Waters Micromass LCT Premier    Waters MA, USA 
XTerra ® MS C18 1.0x50mm; 3.5 µm   Waters MA, USA 
MassLynx v.4.1 software     Micromass Manchester, UK 
Acetonitrile       Merck Darmstad, Germany 
Milli-Q water       Millipore Billerica MA, USA 




LC-MS analyses were performed using two different mass separators, Time-Of-Flight 
and Quadrupole, both equipped with an electrospray ion source. In addition to the active 
fractions, some fractions that did not display any antibacterial activity was also subjected 
to MS analyses to check if it was possible to find the same substances that might be 
found in the active fractions. 
The active fraction 15 from M09038-0-L01-2426 and active fractions 30, 31 and 33 from 
the new primary screening were subjected to ESI-TOF and ESI-Q analyses. The inactive 
fractions tested were 14 and 16 from M09038-0-L01-2426 and 28, 29, 32, 34 and 35 from 
M09038-0-L01 was also tested. The conditions for MS-analyses on ESI-TOF and ESI-Q 
are listed in table 5. The mobile phase gradient used for ESI-TOF and ESI-Q are listed in 
tables 6 and 7.  
 
Table 5: Conditions for MS-analyses for the organic extract M09038 
Conditions ESI-TOF ESI-Q
Cappilary (kV) 2.6 3.3
Cone (V) 35 50
Temperature desolvation (ºC) 300 250
Temperature source (ºC) 120 100
Cone gas flow (L/hr) 5 11
Desolvation gas flow (L/hr) 550 98
Mass range 100-1500 50-1000  
 
Table 6: Gradient used in ESI-TOF 
Flow (µL/min) Tid (min) MP  MP Curve
A % B%
200 0 95 5 -
200 9 30 70 6
200 11 5 95 6
200 19 5 95 6
200 20 95 5 6  
 
Table 7: Gradient used in ESI-Q 
Flow (µL/min) Tid (min) MP  MP Curve
A % B%
50 0 100 0 -
50 45 0 100 6
50 46 100 0 6






The main focus of this thesis was antibacterial activity of the marine organism 
Halocynthia pyriformis, with identification number M09038. In parallel to this two other 
organisms were studied in other projects which focused on antiviral and anticancer 
activities. These other organisms were also included in the antibacterial screening and 
their respective data is presented in this thesis. All three organisms are listed in table 8 
with their individual identification number. In the following text the results of these are 
presented in the tables but not commented further in sampling and storage, but their 
antibacterial activity is addressed in the screening results.  
 
Table 8: The identification numbers and the species these numbers represent.   
Identification number Marine organisms 
a) M09036 Metridium senile 
b) M09037 Parastichopus tremulus
c) M09038 Halocynthia pyriformis  
 
3.1 Sampling and storage 
 
The marine organism was weighed and cut in pieces before it was freeze-dried. The total 
weight of the organism was 954.73 g and the dry weight after freeze-drying was 104.26 g.  
Table 9 shows the total weight of the organism and the dry weight after it was freeze-
dried. The dry weight is also shown as percentage of the total weight.  
 
Table 9: Total weight and dry weight of the marine organisms. Dry weight is the weight of the 
samples after freeze-drying. Dry weight is also shown as the percentage of the total weight.  
Extracts Total weight Dry weight Dry weight
(g) (g) (%)
M09036 1500 152.54 10.2
M09037 995 87.31 8.8
M09038 954.73 104.26 10.9  
 
The freeze-dried material was subjected to an aqueous extraction followed by an organic 
extraction. This resulted in an aqueous and an organic extract which was freeze-dried, 
and weighed. Table 10 shows the weight of the freeze-dried material that resulted from 
the extractions.   
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M09038 * 52.33  
* Data missing.   
 
3.2 UV chromatograms of the aqueous and the organic 
fractions 
 
UV-chromatograms of the aqueous and the organic fractions from all 3 marine organisms 
were obtained after the HPLC purification.  
The UV chromatogram of the aqueous fractions of M09036-0-W01 (figure 7) showed the 
injection top after about two minutes that lasted about a minute. In the following 10 
minutes there were a few smaller peaks and then nothing much until about 38 to 40 
minutes. In the UV chromatogram of the aqueous fractions of M09037-0-W01 (figure 7) 
showed the injection top and then the curve leveled off. The chromatogram of M09038-0-
W01 (figure 7) showed an injection top followed by a couple of peaks in the following 10 
minutes.  
After the injection top there were some smaller peaks detected between the retention 
times of 20 to 30 minutes in the UV chromatogram of the organic fractions of M09036-0-
L01 (figure 8). The UV chromatogram of M09037-0-L01 (figure 8) showed an injection 
peak and two smaller peaks the retention time of 25 to 27 minutes. In addition to the 
standard injection peak the UV chromatogram of M09038-0-L01 (figure 8) a couple of 




Figure 7: The UV-chromatograms of the aqueous fractions in the following order M09036-0-W01 
(top), M09037-0-W01 (middle) and M09038-0-W01 (bottom) are shown in this figure.   
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Figure 8: The UV-chromatograms of the organic fractions in the following order M09036-0-L01 (top), 
M09037-0-L01 (middle) and M09038-0-L01 (bottom) are shown in this figure.   
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3.3 Antibacterial screening 
 
The aqueous and the organic extracts were fractionated into 40 fractions each by HPLC. 
These fractions were screened for antibacterial activity against five bacterial strains 
named E. faecalis, E. coli, P. aeruginosa, S. aureus and MRSA. In any fraction where 
there is a drop in the OD, there is some degree of antibacterial activity. Because of time 
constraints and the need for high throughput there has been defined certain limits that 
defines the activity as interesting to study further. When the OD values were below 0.05 
for the fractions they were defined as active. Values between 0.05 and 0.09 were 
considered as borderline cases which showed some activity. Values above 0.09 were 
considered inactive. The OD was measured at 600 nm. 
 
3.4 Primary screening of the aqueous and organic HPLC 
fractions 
3.4.1 Aqueous HPLC fractions 
 
Fraction 38 from M09036-0-W01 (figure 9a) displayed activity against the bacterial 
strain E. faecalis, and some activity against MRSA and S. aureus. Fraction 38 was tested 
in the secondary screening to confirm the antibacterial activity. The aqueous fractions 
from M09037-0-W01 (figure 9b) and M09038-0-W01 (figure 9c) did not show activity 
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Figure 9: Primary screening: antibacterial activity of the aqueous extracts a) M09036-0-W01, b) 
M09037-0-W01 and c) M09038-0-W01, against five bacterial strains (E. faecalis, E. coli, P. aeruginosa, 
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Figure 9 continued 
 
3.4.2 Organic HPLC fractions  
 
Fraction 26 and 27 from M09036-0-L01 (figure 10a) displayed antibacterial activity. 
Fraction 26 was considered active against S. aureus and MRSA, but also showed some 
activity against E.faecalis. Fraction 27 was considered active against MRSA, but also 
displayed some activity against S. aureus. Some other fractions displayed antibacterial 
activity as well but were above the threshold to be defined as active. Fractions from 
M09037-0-L01 (figure 10b) showed no activity. Fraction 26 from M09038-0-L01 (figure 
10c) was considered active against MRSA, and showed some activity against S. aureus. 
Fractions 24 and 25 displayed some activity against E. faecalis although the activity was 
slightly above the defined limits. The fractions 26 and 27 from M09036-L01 and the 
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Figure 10: Primary screening: antibacterial activity of the organic extracts a) M09036-0-L01, b) 
M09037-0-L01 and c) M09038-0-L01, against five bacterial strains (E. faecalis, E. coli, P. aeruginosa, 
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Figure 10 continued  
 
3.5 Secondary screening of the organic fractions  
 
In order to confirm the activity from the primary screening, the fractions were retested in 
dilutions of 1:1, 1:2 and 1:4, against the bacterial strains E. faecalis, S. aureus and MRSA. 
The fractions retested were 26 and 27 from M09036-0-L01 (figure 11a) and fraction 38 
from M09036-0-W01 (results not shown) and fractions 24, 25 and 26 from M09038-0-
L01 (figure 11b).  
None of the fractions displayed any clear activity against the bacterial strains in any of 
the dilutions. This is demonstrated in figure 11a for the fractions 26 and 27 from 
M09036-0-L01, and in figure 11b for the fractions 24, 25 and 26 from M09038-0-L01. 
The fractions were tested against the bacterial strain E. faecalis. Fractions 24, 25 and 26 
from M09038-0-L01 were selected for further purification even though they did not show 
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any clear activity. The three fractions were pooled and re-fractionated and then subjected 













































Figure 11: Secondary screening: antibacterial activity of the organic fractions a) M09036-0-L01 
fraction 26 and 27, b) M09038-0-L01 fraction 24, 25 and 26 against the bacterial strain E. faecalis. If 
the OD at 600 nm was below 0.05 the fractions were considered active.  
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3.6 Third screening of purified fractions 
 
Fractions 24, 25 and 26 from M09038-0-L01 were pooled and re-fractionated into 40 new 
fractions, and labeled M09038-0-L01-2426. The re-fractionation was performed in an 
attempt to isolate the active compounds. The fractions underwent a third screening 
against the five bacterial strains mentioned. Fraction 15 showed activity against E. 
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Figure 12: Third screening: antibacterial activity of the purified fractions against five bacterial 
strains (E. faecalis, E. coli, P. aeruginosa, S. aureus and MRSA).  
 
3.7 New primary screening of the organic extract M09038 
 
The organic extract M09038 was purified once again by HPLC (figure 13), the fractions 
were concentrated before they were subjected to primary screening. This time fraction 30 
showed some activity against E.faecalis, fraction 31 showed some activity against E. 
faecalis and MRSA, but was considered active against S. aureus. Fraction 33 displayed 
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Figure 13: antibacterial activity found in new primary screening of the organic extract M09038-0-
L01 against five bacterial strains (E. faecalis, E. coli, P. aeruginosa, S. aureus and MRSA). If the OD 
at 600 nm was below 0.05 the fractions were considered active.  
 
There was also performed a dose-response screening on the organic raw-extract M09038 
without purifying it to check for possible activity. The raw-extract showed weak activity 




The fraction M09038-0-L01-2426-15 was analysed by LC-MS using both time-of-flight 
and quadrupole instruments. No compounds were found that could explain the bioactivity 
in this fraction. Some peaks were detected but they were weak and they were also present 
in a number of inactive fractions. Based on the lack of good signals in the MS and the 
weak dose-response effect of the extract it was decided to purify the organic extract 
M09038 once again by HPLC. The organic extract was subjected to primary screening, 
but this time the fractions were more concentrated. The active fractions 30, 31 and 33 
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were analysed directly on ESI-TOF and afterwards with ESI-Q without being re-
fractionated.  
In ESI-TOF the fractions 30, 31 and 33 were analysed in positive and negative mode. 
There were signals detected in fraction 33. Figure 14 shows BPI (Base Peak Index) in 
positive and negative mode of this fraction where two interesting peaks were detected in 
the positive mode. Their respective m/z values were 505.4248, which eluted after 8.93 
minutes, and 269.2094, which eluted after 9.27 minutes. The last peak had the highest 




Figure 14: BPI of m/z 505.4248 and m/z 269.2094 in negative and positive mode. Signals were detected 





Figure 15 shows the ESI-MS spectrum of the peak with the m/z value 269.2094 in 
positive mode. This value was assumed to be the protonated molecular ion; hence the 
molecular weight of this compound was 268.2021 amu. To confirm this, the spectrum 
was searched at higher m/z values for possible adducts which would support this 
conclusion. When searching the spectrum a gap of 22 amu was found between the m/z 
values of 269.2094 and 291.1926 which indicated the sodium adduct [M+Na]+. Another 
gap of 41 amu was found between the m/z values of 310.2395 and 269.2094 that could be 
the adduct containing acetonitrile and a proton [M+ACN+H]+ . The m/z value 310.2395 
was an even number which gave a stronger indication that the adduct contained ACN 
because even numbers indicate the presence of a nitrogen atom. The gap between m/z 
values 332.2197 and 269.2094 was 63 amu indicated the adduct containing ACN and a 
sodium [M+ACN+Na]+. The m/z value 332.2197 was also an even number which meant 
that a nitrogen atom was present. The elemental composition of the compound with 
molecular weight 268.2021 amu was calculated to be C16H28O3.  
The Dictionary of Marine Natural Products is a database which contains isolated 
compounds from plants, animals and microorganisms. The empirical formula C16H28O3 





Figure 15: ESI-TOF spectrum of the peak where the highest m/z value was 269.2094. This was from  
fraction 33 in positive mode.  
 
In the negative spectrum of the peak eluating after 9.27 minutes (figure 16), a signal 
correlating to an adduct with a formate ion ([M+FA-H]-) was detected at m/z 313.2044. 
This finding strengthens the conclusion that 268.2024 is the molecular weight of the 




Figure 16: ESI-TOF spectrum of the peak eluating after 9.27 minutes in fraction 33 in negative mode. 
 
 
Figure 17 shows the ESI-MS spectrum of the other peak with the m/z value 505.4248 in 
positive mode. There were not found any adducts in the spectrum which could confirm 
that 505.4248 was the protonated molecular ion [M+H]+. If it was assumed that the peak 
was [M+H]+, the molecular weight would be 504.4175 amu which gave the proposed 
empirical formula C32H56O4, and if the peak was the [M+Na]+ adduct the molecular 
weight would have been 482.4356 amu, and this gave the proposed formula C31H54N4. 
None of these empirical formulas gave any hits when searching in The Dictionary of 
Marine Natural Products. 
In the negative spectrum of the peak eluating after 8.93 minutes (figure 18), a signal at 
m/z 539.4361 might indicate that there is an adduct with a chloride ion present ([M+Cl]-), 




Figure 17:  ESI-TOF spectrum of the peak where the highest m/z value was 505.4248. This was from 




Figure 18: ESI-TOF spectrum of the peak eluating after 8.93 minutes in fraction 33 in negative mode.  
 
 
In the ESI-Q analysis of the three fractions 30, 31 and 33 there was an m/z peak in 
fraction 33 as well. The assumed protonated molecular ion had an m/z value of 268.8 amu 
which matched the m/z value 269.2094 found in ESI-TOF. The m/z peak 310.2395 
representing the adduct [M+ACN+H]+ was also found in ESI-Q and had a stronger 




4 Discussions  
 
4.1 Antibacterial screening 
 
The evolution of antibiotic-resistant bacteria has made it necessary to look for potent 
antibacterial agents in new places like the marine environment. A marine organism 
named Halocynthia pyriformis (M09038) from the phylum Chordata, in the class 
Ascidiacea, was screened for antibacterial activity. H. pyriformis is a marine invertebrate 
most commonly found in the northern parts of Norway at 20 meters of depth. In addition 
two other marine organisms named Metridium senile (M09036) and Parastichopus 
tremulus (M09037) was screened for antibacterial activity, although the focus of this 
thesis is on the antibacterial activity found in H. pyriformis.     
The aqueous and organic fractions from all 3 marine organisms were screened for 
antibacterial activity against five bacterial strains E. faecalis, E. coli, P. aeruginosa, S. 
aureus and MRSA, where E. faecalis, S. aureus and MRSA are Gram-positive bacteria 
and E. coli and P. aeruginosa is Gram-negative bacteria. The fractions tested had some 
degree of antibacterial activity whenever there was a drop in the OD values, but the need 
for high throughput screening makes it inefficient to investigate every single drop unless 
the activity is within the defined limits of what is considered interesting for further 
studies. The fractions screened in this thesis displayed more activity against Gram-
positive bacteria possibly because of their less complex cell wall making them more 
susceptible to inhibition. 
There were found more antibacterial activity in the organic fractions than in the aqueous 
fractions. A possible explanation could be the difficulties with the isolation and 
purification of water-soluble compounds because of the abundance of salts from sea 
water [21]. The UV-chromatograms obtained from the HPLC purifications showed 
generally more signals in the UV-chromatograms of organic fractions than in the aqueous 
fractions which could confirm that the antibacterial compounds present can be of a more 
lipophilic character. Fraction 38 from M09036-0-W01 displayed clear antibacterial 
activity and its respective UV-chromatogram did detect a signal that indicates the 
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presence of a substance. This could be a compound which is more polar and thus better 
soluble in the aqueous fractions. 
A secondary screening gives an opportunity to check for false positives. Dilutions are 
made to see if the activity could be rediscovered when the fractions are further purified. 
The organic fractions 24, 25 and 26 from H. pyriformis that showed activity in the 
primary screening were tested in secondary screening where the fractions were diluted 
1:1, 1:2 and 1:4. None of the fractions showed any clear activity in any of the dilutions 
based on the limits set by MabCent, but it was possible to notice that they had some 
effect on the bacteria. The normal procedures at Marbio would be to end the screening 
process when there is not found activity in the 1:2 dilutions. The reason for this is that it 
is difficult to rediscover the bioactivity after the re-fractionation of the fractions. The 
concentration of the active compounds in the fractions might be too low to have a clear 
effect. To investigate this further these 3 fractions were pooled and re-fractionated into 40 
new fractions to investigate if they showed activity in the third screening. Fraction 15 
showed a clear drop in bacterial growth and it was subjected to MS-analyses.  
A dose-response test on the raw-extract was performed but showed weak activity. This 
result was unexpected because the fractions of the organic extract did display 
antibacterial activities. The raw-extract is a complex mixture of several compounds and 
the active compounds may be bound to membranes and therefore unable to display 
activity, and also an interaction between the molecules in the extract could mask the 
antibacterial effect of the extract.    
The organic extract of H. pyriformis was once again purified by HPLC but this time the 
fractions were more concentrated before being subjected to a new primary screening in 
the hope of detecting more activity and to confirm the authenticity of the results from the 
primary screening. Fraction 30, 31 and 33 did in fact display clear antibacterial activity 
within the defined limits, which confirmed that the active compounds have to be more 
concentrated in order to inhibit the bacteria more efficiently.  
H. pyriformis has been tested for antibacterial activity before in two other studies. In the 
study performed by Margey Tadesse et al 2008 [22], the antibacterial activity was mostly 
found in the aqueous fractions, and the other study performed by H. Lippert et al 2003, 
found antibacterial activity in the crude organic extract of H. pyriformis [23]. The 
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differences between bioactivity found in this thesis and the other studies could be caused 
by several factors. The same marine organisms are most likely collected from different 
geographical areas and different time of the year which forces them to produce different 
metabolites that are needed for their protection. Another reason for why these findings 
are not comparable with the activity found in this thesis is due to the different extractions 
and screening methods used in all three studies.   
 
4.2 MS- analyses    
 
Mass spectrometry is a technique where the molecular mass of compounds in relation to 
their charge is measured. The purpose of this technique is to find the molecular formula 
of possible active compounds. In order to achieve this, it is essential to first find a signal 
that is assumed to be the molecular ion and then with the help of adducts confirm that it is, 
and by doing so the molecular weight is found, and then the molecular formula can be 
calculated.  
Fraction 30, 31 and 33 from the new primary screening of the organic extract M09038 
were analysed on ESI-TOF and ESI-Q where the analysis of fraction 33 gave a BPI 
chromatogram which contained two peaks that were interesting. These had the m/z values 
505.4248 and 269.2094. Both of these m/z values were investigated and their possible 
empirical formulas were calculated. The molecular weight of 268.2021 amu gave the 
empirical formula C16H28O3. When searched in The Dictionary of Marine Natural 
Products the empirical formula suggested a couple of candidates that had the same 
empirical formula as the possible bioactive compound. It is difficult to know the identity 
of the compound without further analyzing it in NMR, and this requires large amounts of 
pure substance.   
The m/z value 505.4248 amu was assumed to have either the empirical formula C32H56O4 
or C31H54N4. Neither one of the empirical formulas gave any hits in the Dictionary of 
Marine Natural Products, which means that these formulas may represent a new 




If there had been obtained any strong m/z peaks of the protonated molecular ion 505.4248 
amu in quadrupole it had been possible to fragment the compound and it could have been 
analysed using triple quadrupole. The m/z value 505.4248 amu was not detected in 
quadrupole but showed a clear peak in TOF. The explanation for this can be that 
quadrupole loses some sensitivity when scanning for a wide range of ions and have a low 
mass resolution, whereas TOF can analyse an unlimited mass range and have a high mass 
resolution. 
As there are two different unique compounds present in the active fraction, it is 
impossible to conclude if both compounds are bioactive, or if just one of them are. 
Another possibility is that there is a synergistic effect between the two compounds. To 
answer this question, the two compounds have to be isolated and tested individually in 
antibacterial bioassays.   
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